| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ADMA BIOLOGICS, INC. | Director | Common Stock | 56.6K | $256K | $4.52 | Mar 6, 2023 | Indirect |
| ADMA BIOLOGICS, INC. | Director | Employee Stock Option (right to buy) | 51.6K | $189K | $3.66 | Mar 6, 2023 | Direct |
| Alpha Teknova, Inc. | Director | Common Stock | 20K | $34.7K | $1.73 | Jun 26, 2024 | Direct |
| CHIMERIX INC | Director | Stock Option (Right to Buy) | 60K | Jun 20, 2024 | Direct | ||
| Alpha Teknova, Inc. | Director | Non-Qualified Stock Option (right to buy) | 56.7K | Aug 31, 2023 | Direct | ||
| Equillium, Inc. | Director | Stock Option (right to buy) | 20K | May 22, 2024 | Direct | ||
| Adamas Pharmaceuticals Inc | Director | Common Stock | 0 | $5.16 | Nov 24, 2021 | Direct | |
| Adamas Pharmaceuticals Inc | Director | Common Stock | 0 | $5.16 | Nov 24, 2021 | Martha J. Demski U/D/T 10/1/1994, Martha J. Demski Trustee | |
| Adamas Pharmaceuticals Inc | Director | Stock Option (Right to Buy) | 0 | Nov 24, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| TKNO | Alpha Teknova, Inc. | Jun 26, 2024 | 1 | $0 | 4 | Jun 27, 2024 | Director |
| CMRX | CHIMERIX INC | Jun 20, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Director |
| EQ | Equillium, Inc. | May 22, 2024 | 1 | $0 | 4 | May 23, 2024 | Director |
| TKNO | Alpha Teknova, Inc. | Aug 31, 2023 | 1 | $0 | 4 | Sep 5, 2023 | Director |
| TKNO | Alpha Teknova, Inc. | Aug 31, 2023 | 0 | $0 | 3 | Aug 31, 2023 | Director |
| CMRX | CHIMERIX INC | Jun 9, 2023 | 1 | $0 | 4 | Jun 12, 2023 | Director |
| EQ | Equillium, Inc. | May 22, 2023 | 1 | $0 | 4 | May 23, 2023 | Director |
| CMRX | CHIMERIX INC | May 10, 2023 | 1 | $20K | 4 | May 11, 2023 | Director |
| ADMA | ADMA BIOLOGICS, INC. | Mar 6, 2023 | 2 | $0 | 4 | Mar 8, 2023 | Director |
| CMRX | CHIMERIX INC | Jun 23, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
| EQ | Equillium, Inc. | May 24, 2022 | 1 | $0 | 4 | May 25, 2022 | Director |
| CMRX | CHIMERIX INC | May 17, 2022 | 1 | $16.1K | 4 | May 17, 2022 | Director |
| ADMA | ADMA BIOLOGICS, INC. | Mar 7, 2022 | 2 | $0 | 4 | Mar 9, 2022 | Director |
| ADMS | Adamas Pharmaceuticals Inc | Nov 24, 2021 | 5 | $0 | 4 | Nov 24, 2021 | Director |
| CMRX | CHIMERIX INC | Jun 23, 2021 | 1 | $0 | 4 | Jun 25, 2021 | Director |
| ADMS | Adamas Pharmaceuticals Inc | Jun 7, 2021 | 1 | -$10.3K | 4 | Jun 8, 2021 | Director |
| ADMS | Adamas Pharmaceuticals Inc | Jun 2, 2021 | 2 | $0 | 4 | Jun 4, 2021 | Director |
| EQ | Equillium, Inc. | May 26, 2021 | 1 | $0 | 4 | May 28, 2021 | Director |